Literature DB >> 21364860

Type 1 diabetes mellitus and pregnancy.

Roberto Vargas1, John T Repke, Serdar H Ural.   

Abstract

Diabetes complicates up to 10% of all pregnancies in the United States. Of these, 0.2% to 0.5% are patients with type 1 diabetes mellitus (T1DM). Pregnancies affected by T1DM are at increased risk for preterm delivery, preeclampsia, macrosomia, shoulder dystocia, intrauterine fetal demise, fetal growth restriction, cardiac and renal malformations, in addition to rare neural conditions such as sacral agenesis. Intensive glycemic control and preconception planning have been shown to decrease the rate of fetal demise and malformations seen in pregnancies complicated by T1DM. Recent advances in insulin formulations and delivery methods have increased the number of options available to the obstetric team. Insulin regimens should be tailored to each individual patient to maximize compliance and ensure proper glycemic control. Intensive preconception counseling with frequent follow-up visits emphasizing tight glucose control is recommended for adequate management.

Entities:  

Keywords:  Diabetic ketoacidosis; Insulin; Nephropathy; Pregnancy; Type 1 diabetes mellitus

Year:  2010        PMID: 21364860      PMCID: PMC3046748     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN: 1941-2797


  30 in total

1.  Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

Authors:  Maria P Imbergamo; Marco C Amato; Giovanna Sciortino; Massimo Gambina; Maria Accidenti; Angela Criscimanna; Carla Giordano; Aldo Galluzzo
Journal:  Clin Ther       Date:  2008-08       Impact factor: 3.393

2.  Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial.

Authors:  Z Nachum; I Ben-Shlomo; E Weiner; E Shalev
Journal:  BMJ       Date:  1999-11-06

3.  Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro.

Authors:  Sirpa Loukovaara; Ilkka Immonen; Kari Atle Teramo; Risto Kaaja
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

4.  Factors associated with preterm delivery in women with type 1 diabetes: a cohort study.

Authors:  Jacques Lepercq; Joel Coste; Anne Theau; Daniele Dubois-Laforgue; Jose Timsit
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

5.  Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. The National institute of Child health and Human Development Maternal- Fetal Medicine Units Network.

Authors:  B M Sibai; S N Caritis; J C Hauth; C MacPherson; J P VanDorsten; M Klebanoff; M Landon; R H Paul; P J Meis; M Miodovnik; M P Dombrowski; G R Thurnau; A H Moawad; J Roberts
Journal:  Am J Obstet Gynecol       Date:  2000-12       Impact factor: 8.661

6.  Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

Authors:  P Kurtzhals; L Schäffer; A Sørensen; C Kristensen; I Jonassen; C Schmid; T Trüb
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

7.  Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?

Authors:  Lene Ringholm Nielsen; Peter Damm; Elisabeth R Mathiesen
Journal:  Diabetes Care       Date:  2008-10-22       Impact factor: 19.112

8.  Survey of glargine use in 115 pregnant women with Type 1 diabetes.

Authors:  I W Gallen; A Jaap; J M Roland; H H Chirayath
Journal:  Diabet Med       Date:  2008-01-19       Impact factor: 4.359

9.  Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.

Authors:  Elisabeth R Mathiesen; Brendan Kinsley; Stephanie A Amiel; Simon Heller; David McCance; Santiago Duran; Shannon Bellaire; Anne Raben
Journal:  Diabetes Care       Date:  2007-04       Impact factor: 19.112

10.  TNF-alpha is a predictor of insulin resistance in human pregnancy.

Authors:  John P Kirwan; Sylvie Hauguel-De Mouzon; Jacques Lepercq; Jean-Claude Challier; Larraine Huston-Presley; Jacob E Friedman; Satish C Kalhan; Patrick M Catalano
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

View more
  22 in total

1.  Renal efflux transporter expression in pregnant mice with Type I diabetes.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  Toxicol Lett       Date:  2012-04-17       Impact factor: 4.372

Review 2.  Inpatient Glycemic Management of the Pregnant Patient.

Authors:  Tiffany Yeh; Michele Yeung; Felicia A Mendelsohn Curanaj
Journal:  Curr Diab Rep       Date:  2018-08-15       Impact factor: 4.810

3.  Obstetric and neonatal complications among women with autoimmune disease.

Authors:  Andrew Williams; Katherine Grantz; Indulaxmi Seeni; Candace Robledo; Shanshan Li; Marion Ouidir; Carrie Nobles; Pauline Mendola
Journal:  J Autoimmun       Date:  2019-05-27       Impact factor: 7.094

Review 4.  Endocrine and metabolic regulation of renal drug transporters.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2012-08-29       Impact factor: 3.642

5.  Glutathione s-transferase m1 and t1 gene polymorphisms are not associated with increased risk of gestational diabetes mellitus development.

Authors:  O Orhan; M A Atalay; F Orhan; M Karkucak; B Centinkaya Demir; T Yakut; C Cengiz
Journal:  West Indian Med J       Date:  2014-05-15       Impact factor: 0.171

6.  miR-192 is upregulated in T1DM, regulates pancreatic β-cell development and inhibits insulin secretion through suppressing GLP-1 expression.

Authors:  Wen Pan; Yanan Zhang; Chun Zeng; Fen Xu; Jinhua Yan; Jianping Weng
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

Review 7.  Endocrine autoimmune diseases and female infertility.

Authors:  Aritro Sen; Vitaly A Kushnir; David H Barad; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2013-11-05       Impact factor: 43.330

Review 8.  The challenges and future considerations regarding pregnancy-related outcomes in women with pre-existing diabetes.

Authors:  Harsimran Singh; Helen R Murphy; Christel Hendrieckx; Lee Ritterband; Jane Speight
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

9.  Molecular phenotyping of immune cells from young NOD mice reveals abnormal metabolic pathways in the early induction phase of autoimmune diabetes.

Authors:  Jian Wu; Dorothy N Kakoola; Nataliya I Lenchik; Dominic M Desiderio; Dana R Marshall; Ivan C Gerling
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

10.  Preconception risk assessment of infertile couples.

Authors:  Nafisehsadat Nekuei; Ashraf Kazemi; Soheila Ehsanpur; Nastaran Mohammad Ali Beigi
Journal:  Iran J Nurs Midwifery Res       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.